Literature DB >> 12904098

Gastrointestinal side effects of drugs.

Richard Makins1, Anne Ballinger.   

Abstract

Drugs can have adverse effects on any part of the gastrointestinal (GI) tract from mouth to colon. It is essential that a detailed and accurate drug history is taken in patients presenting with GI complaints. Many drug-induced effects will regress or heal on cessation of treatment. NSAIDs are usually associated with gastric and duodenal ulcers but are also recognised to cause lichen planus in the mouth, oesophageal inflammation and strictures, and small bowel and colonic ulcers and strictures. A newer class of anti-inflammatory drugs, the cyclooxygenase-2 (COX-2)-selective inhibitors, have been developed and have a more favourable GI safety profile than standard NSAIDs. Acute diarrhoea, relapse of inflammatory bowel disease (IBD), microscopic colitis and acute pancreatitis are also induced by ingestion of standard NSAIDs. The calcium antagonists, phenytoin and cyclosporin, induce gum hyperplasia, particularly in patients with poor oral hygiene. Alendronate, a bisphosphonate, has been associated with development of oesophageal ulcers, and specific recommendations are now given to reduce this complication. Of the many different forms of colitis associated with drug ingestion, the most frequent is pseudomembranous colitis. This is a complication of antibiotics and is caused by the toxin produced by Clostridium difficile. Many drugs have been associated with the development of acute pancreatitis, although a definite cause and effect relationship has been shown for only a few drugs. These include didanosine, furosomide, corticosteroids, azathioprine and sodium valproate.

Entities:  

Mesh:

Year:  2003        PMID: 12904098     DOI: 10.1517/14740338.2.4.421

Source DB:  PubMed          Journal:  Expert Opin Drug Saf        ISSN: 1474-0338            Impact factor:   4.250


  20 in total

1.  Saliva secretion rate and acidity in a group of physically disabled older care home residents.

Authors:  Gert-Jan van der Putten; Henk S Brand; Luc M J De Visschere; Jos M G A Schols; Cees de Baat
Journal:  Odontology       Date:  2011-12-11       Impact factor: 2.634

Review 2.  Lymphocytic and collagenous colitis: an overview of so-called microscopic colitis.

Authors:  Runjan Chetty; Dhirendra Govender
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2012-02-21       Impact factor: 46.802

3.  Inflammatory responses improve with milk ribonuclease-enriched lactoferrin supplementation in postmenopausal women.

Authors:  Satish Bharadwaj; Tezus A G Naidu; Guru V Betageri; Nemani V Prasadarao; A Satyanarayan Naidu
Journal:  Inflamm Res       Date:  2010-05-15       Impact factor: 4.575

4.  Double-blind pilot study of mesalamine vs. placebo for treatment of chronic diarrhea and nonspecific colitis in immunocompetent HIV patients.

Authors:  Maribel Rodríguez-Torres; Jose F Rodríguez-Orengo; Carlos F Ríos-Bedoya; Alberto Fernández-Carbia; Rosa Salgado-Mercado; Acisclo M Marxuach-Cuétara
Journal:  Dig Dis Sci       Date:  2006-01       Impact factor: 3.199

5.  Iptakalim, an ATP-sensitive potassium channel opener, confers neuroprotection against cerebral ischemia/reperfusion injury in rats by protecting neurovascular unit cells.

Authors:  Yu-hua Ran; Hai Wang
Journal:  J Zhejiang Univ Sci B       Date:  2011-10       Impact factor: 3.066

6.  Milk ribonuclease-enriched lactoferrin induces positive effects on bone turnover markers in postmenopausal women.

Authors:  S Bharadwaj; A G T Naidu; G V Betageri; N V Prasadarao; A S Naidu
Journal:  Osteoporos Int       Date:  2009-01-27       Impact factor: 4.507

7.  Efficacy of 6-mercaptopurine treatment after azathioprine hypersensitivity in inflammatory bowel disease.

Authors:  Ferenc Nagy; Tamas Molnar; Zoltan Szepes; Klaudia Farkas; Tibor Nyari; Janos Lonovics
Journal:  World J Gastroenterol       Date:  2008-07-21       Impact factor: 5.742

8.  A model for chronic mucosal inflammation in IBD and periodontitis.

Authors:  Helieh S Oz; Theresa Chen; Jeffrey L Ebersole
Journal:  Dig Dis Sci       Date:  2009-11-10       Impact factor: 3.199

9.  Severe acute pancreatitis in the elderly: etiology and clinical characteristics.

Authors:  Ming-Jun Xin; Hong Chen; Bin Luo; Jia-Bang Sun
Journal:  World J Gastroenterol       Date:  2008-04-28       Impact factor: 5.742

10.  Angiotensin converting enzyme-inhibitor reduces colitis severity in an IL-10 knockout model.

Authors:  Ryo Sueyoshi; Kathleen M Woods Ignatoski; Stephanie Daignault; Manabu Okawada; Daniel H Teitelbaum
Journal:  Dig Dis Sci       Date:  2013-08-15       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.